(Sharecast News) - Croda International: Berenberg reiterates buy with a target price of 7,400p.
Biffa: Berenberg reiterates buy with a target price of 300p.
Travis Perkins: Canaccord reiterates hold with a target price of 1,525p.
Taylor Wimpey: Canaccord reiterates buy with a target price of 193p.
Croda: Barclays reiterates underweight with a target price of 6,000p.
Metro Bank: Barclays reiterates underweight with a target price of 130p.
Ashtead Group: Barclays reiterates overweight with a target price of 4,340p.
Avast: Peel Hunt reiterates sell with a target price of 355p.
Beazley: Peel Hunt reiterates hold with a target price of 330p.
Serco Group: Liberum reiterates buy with a target price of 180p.
GetBusy: Liberum reiterates buy with a target price of 130p.
BP: JP Morgan reiterates overweight with a target price of 440p.
Man Group: JP Morgan reiterates overweight with a target price of 180p.
Anglo Pacific Group: RBC Capital Markets reiterates outperform with a target price of 240p.
Flutter Entertainment: RBC Capital Markets reiterates sector perform with a target price of 15,700p.
Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,000p.
Bunzl: Deutsche Bank reiterates buy with a target price of 2,850p.
Astrazeneca (AZN)
BP (BP.)
Man (EMG)
Serco (SRP)
Beazley (BEZ)
Travis Perkins (TPK)
Getbusy (GETB)
Bunzl (BNZL)
Metro Bank (MTRO)
Taylor Wimpey (TW.)
Croda International (CRDA)
Ashtead Group (AHT)
Flutter Entertainment (FLTR)Today 09:09
TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US
(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...